Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Related Articles by Review for PubMed (Select 21607603)

1.

SPECT/CT imaging in children with papillary thyroid carcinoma.

Kim HY, Gelfand MJ, Sharp SE.

Pediatr Radiol. 2011 Aug;41(8):1008-12. doi: 10.1007/s00247-011-2039-x. Epub 2011 May 24.

PMID:
21607603
2.

Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer.

Nanni C, Rubello D, Fanti S, Farsad M, Ambrosini V, Rampin L, Banti E, Carpi A, Muzzio P, Franchi R.

Biomed Pharmacother. 2006 Sep;60(8):409-13. Epub 2006 Aug 1. Review.

PMID:
16891093
3.
4.
5.

Role of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients affected by differentiated thyroid carcinoma, high thyroglobulin level, and negative ¹³¹I scan: review of the literature.

Bertagna F, Biasiotto G, Orlando E, Bosio G, Giubbini R.

Jpn J Radiol. 2010 Nov;28(9):629-36. doi: 10.1007/s11604-010-0488-z. Epub 2010 Nov 27. Review.

PMID:
21113746
6.

The role of hybrid SPECT-CT in oncology: current and emerging clinical applications.

Chowdhury FU, Scarsbrook AF.

Clin Radiol. 2008 Mar;63(3):241-51. doi: 10.1016/j.crad.2007.11.008. Epub 2008 Jan 14. Review.

PMID:
18275863
7.

Value of ¹³¹I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature.

Xue YL, Qiu ZL, Song HJ, Luo QY.

Eur J Nucl Med Mol Imaging. 2013 May;40(5):768-78. doi: 10.1007/s00259-012-2310-x. Epub 2012 Dec 15. Review.

PMID:
23242250
8.

Radioiodine scintigraphy with SPECT/CT: an important diagnostic tool for thyroid cancer staging and risk stratification.

Avram AM.

J Nucl Med Technol. 2014 Sep;42(3):170-80. doi: 10.2967/jnumed.111.104133. Review.

PMID:
25190758
9.

Imaging of the thyroid in benign and malignant disease.

Intenzo CM, Dam HQ, Manzone TA, Kim SM.

Semin Nucl Med. 2012 Jan;42(1):49-61. doi: 10.1053/j.semnuclmed.2011.07.004. Review.

PMID:
22117813
10.

Additional diagnostic value of hybrid SPECT-CT systems imaging in patients with differentiated thyroid cancer.

Toubert ME, Vija L, Vercellino L, Banayan S, Faugeron I, Berenger N, Meas T, Marzola MC, Chondrogiannis S, Hindié E, Rubello D.

Am J Clin Oncol. 2014 Jun;37(3):305-13. doi: 10.1097/COC.0b013e3182568fdb. Review.

PMID:
22781388
11.

Molecular imaging agents for SPECT (and SPECT/CT).

Gnanasegaran G, Ballinger JR.

Eur J Nucl Med Mol Imaging. 2014 May;41 Suppl 1:S26-35. doi: 10.1007/s00259-013-2643-0. Epub 2013 Dec 7. Review.

PMID:
24318159
12.

Role of SPECT/CT in differentiated thyroid cancer.

Barwick TD, Dhawan RT, Lewington V.

Nucl Med Commun. 2012 Aug;33(8):787-98. doi: 10.1097/MNM.0b013e3283550257. Review.

PMID:
22669053
13.

SPECT/CT and tumour imaging.

Abikhzer G, Keidar Z.

Eur J Nucl Med Mol Imaging. 2014 May;41 Suppl 1:S67-80. doi: 10.1007/s00259-013-2534-4. Epub 2013 Aug 29. Review.

PMID:
23990144
14.

SPECT/CT in pediatric patient management.

Nadel HR.

Eur J Nucl Med Mol Imaging. 2014 May;41 Suppl 1:S104-14. doi: 10.1007/s00259-014-2697-7. Epub 2014 Feb 20. Review.

PMID:
24554052
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk